Skip to main content
. 2021 Apr 6;12:2043. doi: 10.1038/s41467-021-22319-5

Fig. 4. TRIP12 preferentially interacts with ubiquitylated FBW7.

Fig. 4

a Co-IP confirming endogenous FBW7 interaction with TRIP12 and vice versa in HEK293T cells, black star (*) represents a nonspecific band of unknown identity. b Schematic for experiments in c and d. c In vitro 35S-FBW7α ubiquitylation experiment in the presence of the indicated reagents. d In vitro deubiquitylation of 35S-FBW7α by USP2. e Schematic of in vitro translated 35S-FBW7 pulldown with MYC-TRIP12 from HEK293T cells. f Autoradiograph showing MYC-TRIP12 interaction with ubiquitylated FBW7. g Western blots showing the interaction of MYC-FBW7 with FLAG-TRIP12 in HCT116 cells pre-treated for 24 h with either NAE1 inhibitor (MLN4924) or DMSO as control. h Schematic of GFP-TRIP12 deletion mutants. i Western blots showing the interaction of MYC-FBW7 with GFP-TRIP12, GFP-TRIP12ΔHECT, GFP-TRIP12ΔHECT/ ΔWWE mutants in HCT116 cells, black star (*) represents a nonspecific band of unknown identity. All blots are representative of at least three independent experiments. See also Supplementary Fig. 4. Source data are provided as a Source Data file.